For instance, elevated levels of vascular endothelial growth factor (VEGF) in the bone marrow plasma of patients with AML have been associated with increased angiogenesis, which facilitates leukemia cell survival and proliferation [52,53]. This evidence concerns the gene VEGFA and leukemia.